Andre J. Ouellette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andre J. Ouellette has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Hiroki Tanabe
Department of Pathology, School of Medicine, College of Health Sciences, University of California, Irvine, CA 92697-4800, USA
5 shared publicationsMichael E. Selsted
‡Department of Chemistry Ben-Gurion University of the Negev 84105 Beersheva Israel
4 shared publicationsXiaoqing Qu
Departments of ‡Pathology & Laboratory Medicine and §Microbiology and Molecular Genetics, School of Medicine, College of Health Sciences, University of California, Irvine, California 92697-4800
3 shared publicationsAgnes Henschen-Edman
Third Dept. of Medicine Asahikawa Medical Col- lege 078 Asahikawa Hokkaido Japan
2 shared publicationsAtsuo Maemoto
Departments of ‡Pathology & Laboratory Medicine and §Microbiology and Molecular Genetics, School of Medicine, College of Health Sciences, University of California, Irvine, California 92697-4800
2 shared publicationsColby S. Weeks
Departments of ‡Pathology and Laboratory Medicine and §Microbiology and Molecular Genetics and the ¶Center for Immunology, University of California, Irvine, California 92697-4800
2 shared publications
Latest Publications
- Open Access
- 1 March 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (11) , 6826-6831
Anionic Amino Acids near the Pro-α-defensin N Terminus Mediate Inhibition of Bactericidal Activity in Mouse Pro-cryptdin-4
- 1 March 2009
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (11) , 6826-6831
Open AccessAnionic Amino Acids near the Pro-α-defensin N Terminus Mediate Inhibition of Bactericidal Activity in Mouse Pro-cryptdin-4
- Open Access
- 1 November 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (47) , 32361-32368
In Vitro Activation of the Rhesus Macaque Myeloid α-Defensin Precursor proRMAD-4 by Neutrophil Serine Proteinases
- 1 November 2008
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (47) , 32361-32368
Open AccessIn Vitro Activation of the Rhesus Macaque Myeloid α-Defensin Precursor proRMAD-4 by Neutrophil Serine Proteinases
- 1 January 2006
- Published by Springer Nature
- Vol. 306, 1-25
Paneth Cell α-Defensin Synthesis and Function
Endogenous antimicrobial peptides (AMPs)mediate innate immunity in every species in which they have been investigated. Cathelicidins and defensins are the two major AMP families in mammals, and they are abundant components of phagocytic leukocytes and are released by epithelial cells at mucosal surfaces. In the small intestine, Paneth cells at the base of the crypts of Lieberkühn secrete α-defensins and additional AMPs at high levels in response to cholinergic stimulation and when exposed to bacterial antigens. Paneth cell α-defensins evolved to function in the extracellular environment with broad-spectrum antimicrobial activities, and they constitute the majority of bactericidal peptide activity secreted by Paneth cells. The release of Paneth cell products into the crypt lumen is inferred to protect mitotically active crypt cells from colonization by potential pathogens and confers protection from enteric infection, as is evident from the immunity of mice expressing a human Paneth cell α-defensin transgene to oral infection by Salmonella enterica serovar Typhimurium. α-Defensins in Paneth cell secretions also may interact with bacteria in the intestinal lumen above the crypt-villus boundary and influence the composition of the enteric microbial flora. Mutations that cause defects in the activation, secretion, dissolution, and bactericidal effects of Paneth cell AMPs may alter crypt innate immunity and contribute to immunopathology.
- 1 January 2006
- Published by Springer Nature
- Vol. 306, 1-25
Paneth Cell α-Defensin Synthesis and Function
Endogenous antimicrobial peptides (AMPs)mediate innate immunity in every species in which they have been investigated. Cathelicidins and defensins are the two major AMP families in mammals, and they are abundant components of phagocytic leukocytes and are released by epithelial cells at mucosal surfaces. In the small intestine, Paneth cells at the base of the crypts of Lieberkühn secrete α-defensins and additional AMPs at high levels in response to cholinergic stimulation and when exposed to bacterial antigens. Paneth cell α-defensins evolved to function in the extracellular environment with broad-spectrum antimicrobial activities, and they constitute the majority of bactericidal peptide activity secreted by Paneth cells. The release of Paneth cell products into the crypt lumen is inferred to protect mitotically active crypt cells from colonization by potential pathogens and confers protection from enteric infection, as is evident from the immunity of mice expressing a human Paneth cell α-defensin transgene to oral infection by Salmonella enterica serovar Typhimurium. α-Defensins in Paneth cell secretions also may interact with bacteria in the intestinal lumen above the crypt-villus boundary and influence the composition of the enteric microbial flora. Mutations that cause defects in the activation, secretion, dissolution, and bactericidal effects of Paneth cell AMPs may alter crypt innate immunity and contribute to immunopathology.
- 2 June 2005
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 27 (2) , 133-146
Paneth cell α-defensins: peptide mediators of innate immunity in the small intestine
Epithelial cells contribute to innate immunity by releasing antimicrobial peptides (AMPs) onto mucosal surfaces. In the small bowel, Paneth cells at the base of the crypts of Lieberkühn secrete α-defensins and additional AMPs at high levels in response to cholinergic stimulation and when exposed to bacterial antigens. The release of Paneth cell products into the crypt lumen is inferred to protect mitotically active crypt cells that renew the epithelial cell monolayer from colonization by potentially pathogenic microbes and to confer protection from enteric infection. The most compelling evidence for a Paneth cell role in enteric resistance to infection is evident from studies of mice transgenic for a human Paneth cell α-defensin, HD-5, which are completely immune to infection and systemic disease from orally administered Salmonella enterica serovar typhimurium. Cystic fibrosis mice are subject to small bowel bacterial overgrowth that is associated with impaired dissolution of released Paneth cell granules in the crypt lumen. Mutations that cause defects in the activation, secretion, dissolution, and bactericidal effects of Paneth cell AMPs may alter crypt innate immunity and contribute to immunopathology.
- 2 June 2005
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 27 (2) , 133-146
Paneth cell α-defensins: peptide mediators of innate immunity in the small intestine
Epithelial cells contribute to innate immunity by releasing antimicrobial peptides (AMPs) onto mucosal surfaces. In the small bowel, Paneth cells at the base of the crypts of Lieberkühn secrete α-defensins and additional AMPs at high levels in response to cholinergic stimulation and when exposed to bacterial antigens. The release of Paneth cell products into the crypt lumen is inferred to protect mitotically active crypt cells that renew the epithelial cell monolayer from colonization by potentially pathogenic microbes and to confer protection from enteric infection. The most compelling evidence for a Paneth cell role in enteric resistance to infection is evident from studies of mice transgenic for a human Paneth cell α-defensin, HD-5, which are completely immune to infection and systemic disease from orally administered Salmonella enterica serovar typhimurium. Cystic fibrosis mice are subject to small bowel bacterial overgrowth that is associated with impaired dissolution of released Paneth cell granules in the crypt lumen. Mutations that cause defects in the activation, secretion, dissolution, and bactericidal effects of Paneth cell AMPs may alter crypt innate immunity and contribute to immunopathology.
- Open Access
- 1 April 2005
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (4) , 2312-2320
Mouse Paneth Cell Secretory Responses to Cell Surface Glycolipids of Virulent and Attenuated Pathogenic Bacteria
Mouse Paneth cells respond to bacteria and bacterial cell surface antigens by discharging secretory granules into the lumen of small intestinal crypts (T. Ayabe et al., Nat. Immunol.1:113-118, 2000). To investigate mechanisms regulating these responses, purified surface glycolipid molecules with known acyl chain modifications and attenuated properties were tested for the ability to stimulate Paneth cell secretion. The antigens included lipopolysaccharide (LPS) from wild-type andmsbB-nullEscherichia coliandphoP-null andphoP-constitutiveSalmonella entericaserovar Typhimurium strains, as well as LPS, lipid A, and lipoteichoic acid fromPseudomonas aeruginosaandListeria monocytogenesgrown in Mg2+-limited media. Measurements of total secreted protein, secreted lysozyme, and the bactericidal peptide activities of collected secretions showed that the purified antigens elicited similar secretory responses from Paneth cells in mouse crypts ex vivo, regardless of glycolipid acyl chain modification. Despite their impaired Tlr4 pathway, Paneth cells in ex vivo C3H/HeJ mouse crypts released equivalent amounts of bactericidal peptide activity in response to purified bacterial antigens, including lipid A. Thus, mouse Paneth cells respond equivalently to purified bacterial cell envelope glycolipids, regardless of functional Tlr4, the structural properties of glycolipid acyl chains, or their association with virulence in humans.
- 1 April 2005
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (4) , 2312-2320
Open AccessMouse Paneth Cell Secretory Responses to Cell Surface Glycolipids of Virulent and Attenuated Pathogenic Bacteria
Mouse Paneth cells respond to bacteria and bacterial cell surface antigens by discharging secretory granules into the lumen of small intestinal crypts (T. Ayabe et al., Nat. Immunol.1:113-118, 2000). To investigate mechanisms regulating these responses, purified surface glycolipid molecules with known acyl chain modifications and attenuated properties were tested for the ability to stimulate Paneth cell secretion. The antigens included lipopolysaccharide (LPS) from wild-type andmsbB-nullEscherichia coliandphoP-null andphoP-constitutiveSalmonella entericaserovar Typhimurium strains, as well as LPS, lipid A, and lipoteichoic acid fromPseudomonas aeruginosaandListeria monocytogenesgrown in Mg2+-limited media. Measurements of total secreted protein, secreted lysozyme, and the bactericidal peptide activities of collected secretions showed that the purified antigens elicited similar secretory responses from Paneth cells in mouse crypts ex vivo, regardless of glycolipid acyl chain modification. Despite their impaired Tlr4 pathway, Paneth cells in ex vivo C3H/HeJ mouse crypts released equivalent amounts of bactericidal peptide activity in response to purified bacterial antigens, including lipid A. Thus, mouse Paneth cells respond equivalently to purified bacterial cell envelope glycolipids, regardless of functional Tlr4, the structural properties of glycolipid acyl chains, or their association with virulence in humans.
- Open Access
- 1 October 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (42) , 44188-44196
Functional Analysis of the α-Defensin Disulfide Array in Mouse Cryptdin-4
- 1 October 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (42) , 44188-44196
Open AccessFunctional Analysis of the α-Defensin Disulfide Array in Mouse Cryptdin-4
- 1 April 2004
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 18 (2) , 405-419
Defensin-mediated innate immunity in the small intestine
- 1 April 2004
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 18 (2) , 405-419
Defensin-mediated innate immunity in the small intestine
- Open Access
- 1 March 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (12) , 11976-11983
Structure-Activity Determinants in Paneth Cell α-Defensins
- 1 March 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (12) , 11976-11983
Open AccessStructure-Activity Determinants in Paneth Cell α-Defensins
- 1 March 2004
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (3) , 1470-1478
Paneth Cell α-Defensins from Rhesus Macaque Small Intestine
Antimicrobial peptides are secreted by small intestinal Paneth cells as components of innate immunity. To investigate the role of α-defensins in enteric host defenses in nonhuman primates, α-defensin cDNAs were isolated, α-defensin peptides were purified from rhesus macaque small bowel, and the bactericidal activities of the peptides were measured. Six rhesus enteric α-defensin (RED) cDNAs, RED-1 to RED-6, were identified in a jejunum cDNA library; the deduced RED peptides exhibited extensive diversity relative to the primary structures of rhesus myeloid α-defensins. RED-4 was purified from monkey jejunum, and N-terminal peptide sequencing of putative RED-4 peptides identified two N termini, RTCYCRTGR… and TCYCRTGRC…; these corresponded to alternative N termini for the RED-4 molecules, as deduced from their molecular masses and RED cDNAs. In situ hybridization experiments localized RED mRNAs exclusively to small intestinal Paneth cells. Recombinant RED-1 to RED-4 were purified to homogeneity and shown to be microbicidal in the low micromolar range (≤10 μg/ml) against gram-positive and gram-negative bacteria, with individual peptides exhibiting variable target cell specificities. Thus, compared to myeloid α-defensins from rhesus macaques, enteric α-defensin peptides are highly variable in both primary structure and activity. These studies should facilitate further analyses of the role of α-defensins in primate enteric immunity.
- 1 March 2004
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (3) , 1470-1478
Paneth Cell α-Defensins from Rhesus Macaque Small Intestine
Antimicrobial peptides are secreted by small intestinal Paneth cells as components of innate immunity. To investigate the role of α-defensins in enteric host defenses in nonhuman primates, α-defensin cDNAs were isolated, α-defensin peptides were purified from rhesus macaque small bowel, and the bactericidal activities of the peptides were measured. Six rhesus enteric α-defensin (RED) cDNAs, RED-1 to RED-6, were identified in a jejunum cDNA library; the deduced RED peptides exhibited extensive diversity relative to the primary structures of rhesus myeloid α-defensins. RED-4 was purified from monkey jejunum, and N-terminal peptide sequencing of putative RED-4 peptides identified two N termini, RTCYCRTGR… and TCYCRTGRC…; these corresponded to alternative N termini for the RED-4 molecules, as deduced from their molecular masses and RED cDNAs. In situ hybridization experiments localized RED mRNAs exclusively to small intestinal Paneth cells. Recombinant RED-1 to RED-4 were purified to homogeneity and shown to be microbicidal in the low micromolar range (≤10 μg/ml) against gram-positive and gram-negative bacteria, with individual peptides exhibiting variable target cell specificities. Thus, compared to myeloid α-defensins from rhesus macaques, enteric α-defensin peptides are highly variable in both primary structure and activity. These studies should facilitate further analyses of the role of α-defensins in primate enteric immunity.
- Open Access
- 1 February 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (7) , 5219-5228
Activation of Paneth Cell α-Defensins in Mouse Small Intestine
- 1 February 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (7) , 5219-5228
Open AccessActivation of Paneth Cell α-Defensins in Mouse Small Intestine